Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
VXX-001 by Viravaxx for Hepatitis B: Likelihood of Approval
VXX-001 is under clinical development by Viravaxx and currently in Phase II for Hepatitis B. According to GlobalData, Phase II...